Transfusion thresholds for guiding red blood cell transfusion

Cochrane Database of Systematic Reviews

Volumn 2021, Issue 12, 2021, Pages

  Carson, Jeffrey L ^a   Stanworth, Simon J ^b,c,d   Dennis, Jane A ^e   Trivella, Marialena ^f   Roubinian, Nareg ^g   Fergusson, Dean A ^h   Triulzi, Darrell ⁱ   Dorée, Carolyn ^d   Hébert, Paul C ^j  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NHS BLOOD AND TRANSPLANT   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g DIVISION OF RESEARCH   (United States)

^h OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

ⁱ UNIVERSITY OF PITTSBURGH   (United States)

^j CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ACUTE CORONARY SYNDROME; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE POLICY; HEMATOCRIT; HEMATOLOGIC MALIGNANCY; HOSPITALIZATION; HUMAN; INTERVENTION STUDY; LEUKEMIA; MALIGNANT NEOPLASM; MORBIDITY; MORTALITY; POPULATION RESEARCH; PRACTICE GUIDELINE; PROSPECTIVE STUDY; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; ANEMIA;

ANEMIA; ERYTHROCYTE TRANSFUSION; HEMATOCRIT; HEMOGLOBINS; HUMANS; PROSPECTIVE STUDIES;

EID: 85121984954     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002042.pub5     Document Type: Review

References (207)

1. Akyildiz B, Ulgen Tekerek N, Pamukcu O, Dursun A, Karakukcu M, Narin N, et al. Comprehensive analysis of liberal and restrictive transfusion strategies in pediatric intensive care unit. Journal of Tropical Pediatrics 2018;64(2):118-25. x-wiley/crsRef/16665570
2. Bergamin FS, Almeida JP, Landoni G, Galas F, Fukushima JT, Fominskiy E, et al. Liberal versus restrictive transfusion strategy in critically ill oncologic patients: the transfusion requirements in critically ill oncologic patients: randomized controlled trial. Critical Care Medicine 2017;45(5):766-73. x-wiley/crsRef/16665572
3. Blair SD, Janvrin SB, McCollum CN, Greenhalgh RM. Effect of early blood transfusion on gastrointestinal haemorrhage. British Journal of Surgery 1986;73(10):783-5. x-wiley/crsRef/3132534
4. Bracey AW, Radovancevic R, Riggs SA, Houston S, Cozart H, Vaughn WK, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion 1999;39(10):1070-7. x-wiley/crsRef/3132536
5. Bush RL, Pevec WC, Holcroft JW. A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. American Journal of Surgery 1997;174(2):143-8. x-wiley/crsRef/3132538
6. Carson JL, Terrin ML, Barton FB, Aaron R, Greenburg AG, Heck DA, et al. A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion 1998;38(6):522-9. x-wiley/crsRef/3132540
7. Carson JL, Sieber F, Cook DR, Hoover DR, Noveck H, Chaitman BR, et al. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet 2015;385(9974):1183-9. x-wiley/crsRef/3132542
8. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. New England Journal of Medicine 2011;365(26):2453-62. x-wiley/crsRef/3132543
9. Gruber-Baldini AL, Marcantonio E, Orwig D, Magaziner J, Terrin M, Barr E, et al. Delirium outcomes in a randomized trial of blood transfusion thresholds in hospitalized older adults with hip fracture. Journal of the American Geriatrics Society 2013;61(8):1286-95. x-wiley/crsRef/3132544
10. Carson JL, Brooks MM, Abbott JD, Chaitman B, Kelsey SF, Triulzi DJ, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. American Heart Journal 2013;165(6):964-71. x-wiley/crsRef/3132546 [CTG: NCT01167582]
11. Cooper HA, Rao SV, Greenberg MD, Rumsey MP, Mckenzie M, Alcorn KW, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT randomized pilot study). American Journal of Cardiology 2011;108(8):1108-11. x-wiley/crsRef/3132548
12. de Almeida JP, Vincent JL, Galas FR, de Almeida EP, Fukushima JT, Osawa EA, et al. Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial. Anesthesiology 2015;122(1):29-38. x-wiley/crsRef/3132585
13. DeZern AE, Williams K, Zahurak M, Hand W, Stephens RS, King KE, et al. Red blood cell transfusion triggers in acute leukemia: a randomized pilot study. Transfusion 2016;56(7):1750-7. x-wiley/crsRef/4394246
14. Ducrocq G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, Cachanado M, Durand-Zaleski I, et al. Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia: the REALITY randomized clinical trial. JAMA 2021;325(6):552-60. x-wiley/crsRef/19562781
15. Fan YX, Liu FF, Jia M, Yang JJ, Shen JC, Zhu GM, et al. Comparison of restrictive and liberal transfusion strategy on postoperative delirium in aged patients following total hip replacement: a preliminary study. Archives of Gerontology and Geriatrics 2014;59(1):181-5. x-wiley/crsRef/3132550
16. Foss NB, Kristensen MT, Jensen PS, Palm H, Krasheninnikoff M, Kehlet H. The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery. Transfusion 2009;49(2):227-34. x-wiley/crsRef/3132552
17. Gillies MA, Ghaffar S, Moppett IK, Docherty AB, Clarke S, Rea N, et al. A restrictive versus liberal transfusion strategy to prevent myocardial injury in patients undergoing surgery for fractured neck of femur: a feasibility randomised trial (RESULT-NOF). British Journal of Anaesthesia 2020;126:77-86. x-wiley/crsRef/16665576
18. Gobatto AL, Link MA, Solla DJ, Bassi E, Tierno PF, Paiva W, et al. Transfusion requirements after head trauma: a randomized feasibility controlled trial. Critical Care 2019;23(1):89. x-wiley/crsRef/16665578 [CTG: NCT02203292]
19. Blandfort S, Gregersen M, Borris LC, Damsgaard EM. Blood transfusion strategy and risk of postoperative delirium in nursing homes residents with hip fracture. A post hoc analysis based on the TRIFE randomized controlled trial. Aging Clinical and Experimental Research 2017;29(3):459-66. x-wiley/crsRef/16665579
20. Gregersen M, Borris LC, Damsgaard EM. Blood transfusion and overall quality of life after hip fracture in frail elderly patients - the transfusion requirements in frail elderly randomized controlled trial. Journal of the American Medical Directors Association 2015;16(9):762-6. x-wiley/crsRef/3132554
21. Gregersen M, Borris LC, Damsgaard EM. Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture: the TRIFE randomized controlled trial. Acta Orthopaedica 2015;86(3):1-10. x-wiley/crsRef/3132555
22. Gregersen M, Damsgaard EM, Borris LC. Blood transfusion and risk of infection in frail elderly after hip fracture surgery: the TRIFE randomized controlled trial. European Journal of Orthopaedic Surgery & Traumatology 2015;25(6):1031-8. x-wiley/crsRef/3132556
23. Grover M, Talwalkar S, Casbard A, Boralessa H, Contreras M, Boralessa H, et al. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sanguinis 2006;90(2):105-12. x-wiley/crsRef/3132558
24. Grover M, Talwalker SA, Contreras, Soni N. Blood transfusion threshold and silent myocardial ischemia after lower limb arthroplasty: a randomized controlled trial of transfusion strategy. Transfusion Alternatives in Transfusion Medicine 2005;7(1 (Suppl)):62-3. x-wiley/crsRef/3132559
25. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010;304(14):1559-67. x-wiley/crsRef/3132561
26. Hébert PC, Wells G, Marshall J, Martin C, Tweeddale M, Pagliarello G, et al. Transfusion requirements in critical care. A pilot study. Canadian Critical Care Trials Group [published erratum appears in JAMA 1995 Sep 27;274(12):944]. JAMA 1995;273(18):1439-44. x-wiley/crsRef/3132563
27. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. New England Journal of Medicine 1999;340(6):409-17. x-wiley/crsRef/3132565
28. McIntyre L, Hébert PC, Wells G, Fergusson D, Marshall J, Yetisir E, et al, Canadian Critical Care Trials Group. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? Journal of Trauma 2004;57(3):563-8. x-wiley/crsRef/3132566
29. Hoff CM, Hansen HS, Overgaard M, Grau C, Johansen J, Bentzen O, et al. The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy - results from the randomized DAHANCA 5 study. Radiotherapy and Oncology 2011;1998:28-33. x-wiley/crsRef/19562783 [DOI: 10.1016/j.radonc.2010.09.024]
30. Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, et al. Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? Results from the randomized DAHANCA 5 and 7 trials. Acta Oncologica 2011;50(7):1006-14. x-wiley/crsRef/19562784
31. Overgaard J, Hansen HS, Overgaard M, Bastholt L, Berthelsen A, Specht L, et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma: results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiotherapy and Oncology 1998;46:135-46. x-wiley/crsRef/19562785
32. Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Anderson E, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 & 7 randomised controlled trial. Lancet 2003;362:933-40. x-wiley/crsRef/19562786
33. Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. New England Journal of Medicine 2014;371(15):1381-91. x-wiley/crsRef/16665580
34. Rygård SL, Holst LB, Wetterslev J, Winkel P, Johansson PI, Wernerman J, et al, TRISS Trial Group, Scandinavian Critical Care Trials Group. Long-term outcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold: the TRISS randomised, multicentre clinical trial. Intensive Care Medicine 2016;42(11):1685-94. x-wiley/crsRef/16665581
35. Campbell HE, Stokes EA, Bargo D, Logan RF, Mora A, Hodge R, et al. Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial. BMJ Open 2015;5(4):e007230. x-wiley/crsRef/19562787
36. Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, James MW, et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet 2015;386(9989):137-44. x-wiley/crsRef/3132571 [ISRCTN: ISRCTN85757829]
37. Jansen AJ, van den Bosch J. Results of the prematurely terminated TEMPLE randomized controlled trial in patients with myelodysplastic syndrome: liberal versus restrictive red blood cell transfusion threshold [Letter to the Editor]. Transfusion 2020;60(4):879-81. x-wiley/crsRef/16665583 [ISRCTN: ISRCTN43616311]
38. Johnson RG, Thurer RL, Kruskall MS, Sirois C, Gervino EV, Critchlow J, et al. Comparison of two transfusion strategies after elective operations for myocardial revascularization. Journal of Thoracic and Cardiovascular Surgery 1992;104(2):307-14. x-wiley/crsRef/3132573
39. Koch CG, Sessler DI, Mascha EJ, Sabik JF 3rd, Li L, Duncan AI, et al. A randomized clinical trial of red blood cell transfusion triggers in cardiac surgery. Annals of Thoracic Surgery 2017;104(4):1243-50. x-wiley/crsRef/16665585
40. Kola G, Sureshkumar S, Mohsina S, Sreenath GS, Kate V. Restrictive versus liberal transfusion strategy in upper gastrointestinal bleeding: a randomized controlled trial. Saudi Journal of Gastroenterology 2020;27(1):13-9. x-wiley/crsRef/16665587 [DOI: 10.4103/sjg.SJG_152_20]
41. Lacroix J, Hébert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, et al. Transfusion strategies for patients in pediatric intensive care units. New England Journal of Medicine 2007;356(16):1609-19. x-wiley/crsRef/3132575
42. Laine, A, Niemi, T, Schramko Al. Transfusion threshold of hemoglobin 80g/L is comparable to 100g/L in terms of bleeding in cardiac surgery: a prospective randomized study. Journal of Cardiothoracic and Vascular Anesthesia 2018;32(1):131-9. x-wiley/crsRef/16665589
43. Lotke PA, Barth P, Garino JP, Cook EF. Predonated autologous blood transfusions after total knee arthroplasty: immediate versus delayed administration. Journal of Arthroplasty 1999;14(6):647-50. x-wiley/crsRef/3132577
44. Galan J, Mateo E, Carmona P, Gajate L, Mazer CD, Martinez-Zapata MJ. Restrictive or liberal transfusion for cardiac surgery: Spanish TRICCS results of a randomized multicenter international parallel open-label clinical trial [Transfusión Restrictiva o liberal en cirugía cardiaca: Resultados españoles de un ensayo clínico aleatorizado, multicéntrico, internacional, paralelo y abierto]. Medicina Intensiva (English edition) 2020;In press/epub: no volume:Epub: no pagination. x-wiley/crsRef/19562788 [DOI: 10.1016/j.medin.2020.07.011]
45. Garg AX, Badner N, Bagshaw SM, Cuerden MS, Fergusson DA, Gregory AJ, et al, TRICS Investigators and Perioperative Anesthesia Clinical Trials Group. Safety of a restrictive versus liberal approach to red blood cell transfusion on the outcome of AKI in patients undergoing cardiac surgery: a randomized clinical trial. Journal of the American Society of Nephrology: JASN 2019;30(7):1294-304. x-wiley/crsRef/16665591
46. Mazer CD, Whitlock RP, Fergusson DA, Belley-Cote E, Connolly K, Khanykin B, et al, TRICS Investigators and Perioperative Anesthesia Clinical Trials Group. Restrictive or liberal red-cell transfusion for cardiac surgery. New England Journal of Medicine 2017;377(22):2133-44. x-wiley/crsRef/16665593
47. Mazer CD, Whitlock RP, Fergusson DA, Belley-Cote E, Connolly K, Khanykin B, TRICS Investigators and Perioperative Anesthesia Clinical Trials Group. Six-month outcomes after restrictive or liberal transfusion for cardiac surgery. New England Journal of Medicine 2018;379(13):1224-33. x-wiley/crsRef/16665592
48. Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD, et al. Liberal or restrictive transfusion after cardiac surgery. New England Journal of Medicine 2015;372:997-1008. x-wiley/crsRef/3132579
49. Stokes EA, Wordsworth S, Bargo D, Pike K, Rogers CA, Brierley RC, et al. Are lower levels of red blood cell transfusion more cost-effective than liberal levels after cardiac surgery? Findings from the TITRe2 randomised controlled trial. BMJ Open 2016;6(8):e011311. x-wiley/crsRef/19562789
50. Møller A, Nielsen HB, Wetterslev J, Pedersen OB, Hellemann D, Winkel P, et al. Low vs high hemoglobin trigger for transfusion in vascular surgery: a randomized clinical feasibility trial. Blood 2019;133(25):2639-50. x-wiley/crsRef/16665595
51. Møller A, Shahidi S, Wetterslev J, Helleman D, Pedersen OB, Marcussen KV, et al. Cardiac output in the transfusion triggers in vascular surgery trial. Acta Anaesthesiologica Scandinavica 2019;63:e12. x-wiley/crsRef/16665596
52. Nielsen K, Johansson PI, Dahl B, Wagner M, Frausing B, Børglum J, et al. Perioperative transfusion threshold and ambulation after hip revision surgery - a randomized trial. BMC Anesthesiology 2014;14:89-98. x-wiley/crsRef/3132581
53. Palmieri TL, Holmes JH, Arnoldo B, Peck M, Cochran A, King BT, et al. Restrictive transfusion strategy is more effective in massive burns: results of the TRIBE multicenter prospective randomized trial. Military Medicine 2019;184 (Suppl 1):11-5. x-wiley/crsRef/16665598 [DOI: doi: 10.1093/milmed/usy279]
54. Palmieri TL, Holmes JH, Arnoldo B, Peck M, Potenza B, Cochran A, et al. Transfusion requirement in burn care evaluation (TRIBE). A multicenter randomized prospective trial of blood transfusion in major burn injury. Annals of Surgery 2017;266:595-602. x-wiley/crsRef/16665599
55. Parker MJ. Randomised trial of blood transfusion versus a restrictive transfusion policy after hip fracture surgery. Injury 2013;44(12):1916-8. x-wiley/crsRef/3132583
56. Prick BW, Duvekot JJ, van der Moer PE, van Gemund N, van der Salm PC, Jansen AJ, et al. Cost-effectiveness of red blood cell transfusion vs. non-intervention in women with acute anaemia after postpartum haemorrhage. Vox Sanguinis 2014;107(4):381-8. x-wiley/crsRef/19562790 [DOI: 10.1111/vox.12181]
57. Prick BW, Jansen AJ, Steegers EA, Hop WC, Essink-Bot ML, Uyl-de Groot CA, et al. Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial. BJOG 2014;121(8):1005-14. x-wiley/crsRef/3132587
58. Robitaille N, Lacroix J, Alexandrov L, Clayton L, Cortier M, Schultz KR, et al. Excess of veno-occlusive disease in a randomized trial on a higher trigger for red cell transfusion after bone marrow transplantation: a Canadian blood and marrow transplant group trial. Biology of Blood and Marrow Transplantation 2013;19:468-73. x-wiley/crsRef/19562792
59. Shehata N, Burns LA, Nathan H, Hebert P, Hare GM, Fergusson D, et al. A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery. Transfusion 2012;52(1):91-9. x-wiley/crsRef/3132589
60. So-Osman C, Nelissen R, Brand R, Faber F, Slaa RT, Stiggelbout A, et al. The impact of a restrictive transfusion trigger on post-operative complication rate and well-being following elective orthopaedic surgery: a post-hoc analysis of a randomised study. Blood Transfusion (Trasfusione del sangue) 2013;11(2):289-95. x-wiley/crsRef/3132591
61. So-Osman C, Nelissen R, Te Slaa R, Coene L, Brand R, Brand A. A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells. Vox Sanguinis 2010;98(1):56-64. x-wiley/crsRef/3132592
62. So-Osman C. A restrictive transfusion trigger is a method for blood saving in elective orthopaedic surgery. Vox Sanguinis 2004;87(Suppl 3):52. x-wiley/crsRef/3132593
63. Stanworth SJ, Killick S, McQuilten ZK, Karakantza M, Weinkove R, Smethurst H, et al, REDDS Investigators. Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial. British Journal of Haematology 2020;189(2):279-90. x-wiley/crsRef/16665601 [ISRCTN26088319]
64. Tay J, Allan DS, Chatelain E, Coyle D, Elemary M, Fulford A, et al. Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial. Journal of Clinical Oncology 2020;38(13):1463-73. x-wiley/crsRef/16665603
65. Fisher MR, Topley ET. The illness of trauma. British Journal of Clinical Practice 1956;10(11):770-6. x-wiley/crsRef/16665605
66. Colomo A, Hernandez-Gea V, Muniz-Diaz E, Madoz P, Aracil C, Alvarez-Urturi C. Transfusion strategies in patients with cirrhosis and acute gastrointestinal bleeding. Hepatology 2008;48(4 Suppl):413A. x-wiley/crsRef/4394247
67. Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. New England Journal of Medicine 2013;368(1):11-21. x-wiley/crsRef/3132597
68. Walsh TS, Boyd JA, Watson D, Hope D, Lewis S, Krishan A, et al. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial. Critical Care Medicine 2013;41(10):2354-63. x-wiley/crsRef/3132599
69. Webert KE, Cook RJ, Couban S, Carruthers J, Lee KA, Blajchman MA, et al. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion 2008;48(1):81-91. x-wiley/crsRef/3132601
70. Yakymenko D, Frandsen KB, Christensen IJ, Norgaard A, Johansson PI, Daugaard G, et al. Randomised feasibility study of a more liberal haemoglobin trigger for red blood cell transfusion compared to standard practice in anaemic cancer patients treated with chemotherapy. Transfusion Medicine 2018;28(3):208-15. x-wiley/crsRef/16665607
71. Atilla E, Toprak SK, Civriz Bozdag S, Topcuoglu P, Arslan O. A randomized comparison of hemoglobin content-based versus standard (unit-based) red blood cell transfusion policy. Turkish Journal of Haematology 2017;34(244):244-9. x-wiley/crsRef/19562794
72. Baron-Stefaniak J, Leitner GC, Kuntzel NKI, Meyer EL, Hiesmayr MJ, Ullrich R, et al. Transfusion of standard-issue packed red blood cells induces pulmonary vasoconstriction in critically ill patients after cardiac surgery - a randomized,double-blinded, clinical trial. PLOS One 2019;14(3):e0213000. x-wiley/crsRef/19562796
73. Cholette JM, Swartz MF, Rubenstein J, Henrichs KF, Wang H, Powers KS. Outcomes using a conservative versus liberal red blood cell transfusion strategy in infants requiring cardiac operation. Annals of Thoracic Surgery 2017;103(1):206-14. x-wiley/crsRef/16665615
74. de Bruin S, Scheeren TW, Bakker J, van Bruggen R, Vlaar AP, Cardiovascular Dynamics Section and Transfusion Guideline Task Force of the ESICM. Cardiovascular Dynamics Section and Transfusion Guideline Task Force of the ESICM. Transfusion practice in the non-bleeding critically ill: an international online survey - the TRACE survey. Critical Care 2019;23:309. x-wiley/crsRef/19562798 [DOI: 10.1186/s13054-019-2591-6]
75. Elshinawy M, Al Marhoobi N, Al Abri R, Nazir HF, Khater D, Maktoom M, et al. Preoperative transfusion versus no transfusion policy in sickle cell disease patients: a randomized trial. Transfusion 2020;60(Suppl 1):S22-7. x-wiley/crsRef/19562800
76. Fogagnolo A, Taccone FS, Vincent JL, Benetto G, Cavalcante E, Marangoni E, et al. Using arterial-venous oxygen difference to guide red blood cell transfusion strategy. Critical Care 2020;24:160. x-wiley/crsRef/16665623
77. Fortune JB, Feustel PJ, Saifi J, Stratton HH, Newell JC, Shah DM. Influence of hematocrit on cardiopulmonary function after acute hemorrhage. Journal of Trauma 1987;27(3):243-9. x-wiley/crsRef/3132603
78. Franz AR, Engel C, Bassler D, Rüdiger M, Thome UH, Maier RF, et al, the ETTNO Investigators. Effects of liberal vs restrictive transfusion thresholds on survival and neurocognitive outcomes in extremely low-birth-weight infants: the ETTNO randomized clinical trial. JAMA 2020;324:560-70. x-wiley/crsRef/16665625 [CTG: NCT01393496] [EUCTR: EUCTR2010-021576-28-DE]
79. Haensig M, Kempfert J, Kempfert PM, Girdauskas E, Borger MA, Lehmann S. Thrombelastometry guided blood-component therapy after cardiac surgery: a randomized study. BMC Anesthesiology 2019;19(1):201. x-wiley/crsRef/19562802 [DOI: 10.1186/s12871-019-0875-7]
80. Hamm RF, Perelman S, Wang EY, Levine LD, Srinivas SK. Single-unit vs multiple-unit transfusion in hemodynamically stable postpartum anemia: a pragmatic randomized controlled trial. American Journal of Obstetrics & Gynecology 2021;224(84):e1-7.0002-9378/. x-wiley/crsRef/16665629 [CTG: NCT03419780]
81. Jain A, Raja A, Marwaha N, Trehan A. Comparison of efficacy of packed red blood cell transfusion based on its hemoglobin content versus the routine transfusion practice in thalassemia major patients. Vox Sanguinis 2019;114:213. x-wiley/crsRef/19562803
82. Raja A, Jain A, Marwaha N, Trehan A. Comparison of efficacy of packed red blood cell transfusion based on its hemoglobin content versus the standard transfusion practice in thalassemia major patients (HEMOCON study). Transfusion and Apheresis Science 2020;59:6 (Article ID: 102736). x-wiley/crsRef/19562804 [DOI: doi.org/10.1016/j.transci.2020.102736]
83. Kirpalani H, Bell EF, Hintz SR, Tan S, Schmidt B, Chaudhary AS, et al. Higher or lower hemoglobin transfusion thresholds for preterm infants. New England Journal of Medicine 2020;383(27):2639-51. x-wiley/crsRef/19562806
84. Koster A, Zittermann A, Borgermann J, Knabbe C, Diekmann J, Schirmer U, et al. Transfusion of 1 and 2 units of red blood cells does not increase mortality and organ failure in patients undergoing isolated coronary artery bypass grafting. European Journal of Cardio-thoracic Surgery 2016;49:931-6. x-wiley/crsRef/19562808
85. Kumar M, Ahmad J, Maiwall R, Choudhury A, Bajpai M, Mitra LG, et al. Thromboelastography-guided blood component use in patients with cirrhosis with nonvariceal bleeding: a randomized controlled trial. Hepatology 2019;71(1):235-46. x-wiley/crsRef/19562810
86. Leal-Noval SR, Arellano-Orden V, Maestre-Romero A, Muñoz-Gómez M, Fernández-Cisneros V, Ferrándiz-Millón C, et al. Red blood cell transfusion guided by near nfrared spectroscopy in neurocritically ill patients with moderate or severe anemia: a randomized, controlled trial. Journal of Neurotrauma 2017;34(17):2553-9. x-wiley/crsRef/16665641
87. Osawa EA, Rhodes A, Landoni G, Galas FR, Fukushima JT, Park CH, et al. Effect of perioperative goal-directed hemodynamic resuscitation therapy on outcomes following cardiac surgery: a randomized clinical trial and systematic review. Critical Care Medicine 2016;44(4):724-33. x-wiley/crsRef/16665647 [DOI: 10.1097/CCM.0000000000001479]
88. Robertson CS, Hannay HJ, Yamal JM, Gopinath S, Goodman JC, Tilley BC, et al. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA 2014;312(1):36-47. x-wiley/crsRef/3132605
89. Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. New England Journal of Medicine 1995;333(4):206-13. x-wiley/crsRef/3132607
90. Voorn VM, Marang-van de Mheen PJ, van der Hout A, Hofstede SN, So-Osman C, van den Akker-van Marle ME, et al. The effectiveness of a de-implementation strategy to reduce low-value blood management techniques in primary hip and knee arthroplasty: a pragmatic cluster-randomized controlled trial. Implementation Science 2017;12(1):72. x-wiley/crsRef/16665657 [DOI: 10.1186/s13012-017-0601-0]
91. Yamada C, Takeshita A, Ohto H, Ishimaru K, Kawabata K, Nomaguchi Y, et al. A Japanese multi-institutional collaborative study of antigen-positive red blood cell (RBC) transfusions in patients with corresponding RBC antibodies. Vox Sanguinis 2020;115(5):456-65. x-wiley/crsRef/19562812
92. Zygun DA, Nortje J, Hutchinson PJ, Timofeev I, Menon DK, Gupta AK. The effect of red blood cell transfusion on cerebral oxygenation and metabolism after severe traumatic brain injury. Critical Care Medicine 2009;37(3):1074-8. x-wiley/crsRef/3132609
93. IRCT20190209042660N1. A clinical trial on comparing morbidity and mortality of restrictive blood transfusion strategy with a traditional strategy in patients with a thermal burn. Iranian Registry of Clinical Trials - Beta version. https://en.irct.ir/trial/43402 (first posted 15 June 2020). x-wiley/crsRef/19562814
94. ISRCTN26088319. Red cell transfusion and QoL in myelodysplastic syndromes [Red blood cell transfusion thresholds and quality of life in myelodysplastic syndromes: a pilot, feasibility study]. www.isrctn.com/ISRCTN26088319 (first received 13 November 2014). x-wiley/crsRef/4394249
95. Maitland K, Kiguli S, Olupot-Olupot, Engoru C, Mallewa M, Saramago Goncalves P, et al, the TRACT Group. Immediate transfusion in African children with uncomplicated severe anaemia. New England Journal of Medicine 2019;381(5):407-19. x-wiley/crsRef/19562816 [DOI: 10.1056/NEJMoa1900105] [ISRCTN: ISRCTN84086586]
96. Maitland K, Polupot-Olupot P, Kiguli S, Chagaluka G, Alaroker F, Opoka RO, et al, TRACT Group. Transfusion volume for children with severe anemia in Africa. New England Journal of Medicine 2019;381(5):420-31. x-wiley/crsRef/19562817 [DOI: 10.1056/NEJMoa1900100]
97. Morton S, Sekhar M, Smethurst H, Mora S, Hodge R, Hudson C, et al. Results for the REAL pilot randomised trial of red cell transfusion in acute myeloid leukaemia: is there sufficient evidence of equipoise to support a definitive study? British Journal of Haematology 2020;189 (Suppl 1):36-7. x-wiley/crsRef/16665666 [ISRCTN: ISRCTN96390716]
98. Buckstein RJ, Prica A, Leber B, Heddle N, Yee KW, Stanworth SJ, et al. RBC-Enhance: a randomized pilot feasibility trial of red cell transfusion thresholds in myelodysplastic syndromes. Blood 2020;136(Suppl 1):3-4. x-wiley/crsRef/19562818 [CTG: NCT02099669]
99. NCT02099669. Red blood cell transfusion thresholds and QOL in MDS (EnhanceRBC): a pilot, feasibility study. www.clinicaltrials.gov/ct2/show/NCT02099669 2014 (last accessed 6/7/21). x-wiley/crsRef/4394257 [CTG: NCT02099669]
100. ACTRN12619001053112. Red blood cell transfusion schedule in myelodysplastic syndromes: study 2 (REDDS-2) [A randomised feasibility n-of-1 trial of weekly-interval red cell transfusion myelodysplastic syndromes]. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377401&isReview=true (first received 4 June 2019). [ACTRN: ACTRN12619001053112] x-wiley/crsRef/19562820
101. Hayakawa M, Tagami T, IIjima H, Kudo D, Sekine K, Ogura T, et al. Restrictive transfusion strategy for critically injured patients (RESTRIC) trial: a study protocol for a cluster-randomised, crossover non-inferiority trial. BMJ Open 2020 2020;10(9):e037238. x-wiley/crsRef/16665631 [UMIN000034405]
102. ISRCTN17438123. A small pilot feasibility study for a possible randomised control trial comparing clinical outcomes and quality of life following two different transfusion strategies in children undergoing allogeneic hematopoietic stem cell transplant (HSCT) [RePAST: Red cell transfusion in Paediatric Allogeneic HSCT - A feasibility randomised controlled trial comparing restrictive versus liberal red cell (RBC) transfusion strategies in children undergoing allogeneic haematopoietic stem cell transplant (HSCT)]. www.isrctn.com/ISRCTN17438123 (first posted 23 May 2019). x-wiley/crsRef/19562822 [ISRCTN: ISRCTN17438123]
103. Meybohm P, Lindau S, Treskatsch S, Francis R, Spies C, Velten M, et al, LIBERAL Collaboration Group. Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients - The study design of the LIBERAL-Trial. Trials 2019;20(1):101. x-wiley/crsRef/16665645 [CTG: NCT03369210] [DOI: 10.1186/s13063-019-3200-3]
104. NCT02619136. Myocardial ischemia and transfusion (MINT) [Myocardial ischemia and transfusion: a pilot, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in patients with myocardial infarction]. www.clinicaltrials.gov/ct2/show/NCT02619136 (first posted 2 December 2015). x-wiley/crsRef/19562824 [CTG: NCT02619136]
105. NCT02981407. Myocardial Ischemia and Transfusion (MINT). clinicaltrials.gov/ct2/show/NCT02981407 (first posted 5 December 2016). x-wiley/crsRef/19562825 [CTG: NCT02981407]
106. NCT03229941. Transfusion trigger after operations in high cardiac risk patients (TOP) [CSP #599 - Transfusion trigger after operations in high cardiac risk patients (TOP)]. clinicaltrials.gov/ct2/show/NCT03229941 (first posted 26 July 2017). x-wiley/crsRef/19562827 [CTG: NCT03229941]
107. NCT03260478. HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial (HEMOTION). clinicaltrials.gov/ct2/show/NCT03260478 (first posted 24 August 2017). x-wiley/crsRef/19562829
108. English SW, Fergusson D, Chassé M, Turgeon AF, Lauzier F, Griesdale D, et al, Canadian Critical Care Trials Group. Aneurysmal SubArachnoid Hemorrhage - Red Blood Cell Transfusion And Outcome (SAHaRA): a pilot randomised controlled trial protocol. BMJ Open 2016;6(12):e012623. x-wiley/crsRef/19562831 [CTG: NCT02483351]
109. NCT02483351. Aneurysmal subarachnoid hemorrhage: red blood cell transfusion and outcome (SAHaRA Pilot) [Aneurysmal subarachnoid hemorrhage: red blood cell transfusion and outcome - a pilot randomized controlled trial]. www.clinicaltrials.gov/ct2/show/NCT02483351 (first received 26 June 2015). x-wiley/crsRef/19562832 [CTG: NCT02483351]
110. NCT3309579. SAHaRA: a randomized controlled trial [Aneurysmal subarachnoid hemorrhage - red blood cell transfusion and outcome (SAHaRA): a randomized controlled trial]. clinicaltrials.gov/ct2/show/NCT03309579 (first received 13 October 2017). x-wiley/crsRef/19562833 [CTG: NCT3309579]
111. NCT03871244. Pilot Optimizing Transfusion Thresholds in Critically-ill Children with Anaemia (P-OpTTICCA) [Pilot Optimizing Transfusion Thresholds in Critically-ill Children with Anaemia (P-OpTTICCA): a pilot trial for a large pragmatic international parallel open-label non-inferiority randomised controlled trial]. clinicaltrials.gov/ct2/show/NCT03871244 (first posted 12 March 2019). x-wiley/crsRef/19562835 [CTG: NCT03871244]
112. NCT04506125. Liberal versus restrictive transfusion threshold in oncologic surgery (LIBERTY1) [Liberal versus restrictive transfusion threshold in oncologic surgery: a multicenter, randomized, controlled, pilot study]. clinicaltrials.gov/ct2/show/NCT04506125 (first posted 10 August 2020). x-wiley/crsRef/19562836 [CTG: NCT04506125]
113. NCT04591574. ABC - a post intensive care anaemia management trial [Anaemia management with red blood cell transfusion to improve post-intensive care disability: a randomised controlled trial (the ABC post-intensive care trial)]. https://clinicaltrials.gov/ct2/show/NCT04591574 (first accepted 19 October 2020). x-wiley/crsRef/19562838
114. NCT04754022. Transfusion requirements in younger patients undergoing cardiac surgery (TRICS-IV) [An international, multi-centre, randomized controlled trial to assess transfusion thresholds in younger patients undergoing cardiac surgery]. www.clinicaltrials.gov/ct2/show/NCT04754022 (first posted 15 February 2021). x-wiley/crsRef/19562840 [CTG: NCT04754022]
115. The impact of REstrictive versus LIberal Transfusion strategy on cardiac injury and death in patients undergoing surgery for Hip Fracture (RESULT-Hip). Ongoing study. 2022. Contact author for more information.
116. NL3090 NTR3244. Blood transfusion study in patients at risk for cardiac complications after non-cardiac surgery [Perioperative Transfusion Study (PETS): does a liberal transfusion protocol improve outcome in high-risk cardiovascular patients undergoing non-cardiac surgery?]. www.trialregister.nl/trial/3090 (first posted 17 January 2012). x-wiley/crsRef/19562843
117. Association of Anaesthetists of Great Britain and Ireland. Blood transfusion and the anaesthetist - red cell transfusion. www.aagbi.org/publications/guidelines/docs/red_cell_08.pdf 2008 (accessed 11 October 2016).
118. American Society of Anesthesiologists (ASA) Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006;105(1):198-208.
119. Baek JH, Buehler PW. Can molecular markers of oxygen homeostasis and the measurement of tissue oxygen be leveraged to optimize red blood cell transfusions? Current Opinion in Hematology 2019;26(6):453-60. [DOI: 10.1097/MOH.0000000000000533]
120. British Columbia Transfusion Medicine Advisory Group (BCTMAG). Guidelines for red blood cell transfusion. British Columbia Transfusion Medicine Advisory Group 2003;November:1-3.
121. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. New England Journal of Medicine 2000;342(25):1878-86.
122. Butcher A, Richards T, Stanworth SJ, Klein AA. Diagnostic criteria for pre-operative anaemia - time to end sex discrimination. Anaesthesia 2017;72(7):811-4.
123. Campbell HE, Stokes EA, Bargo D, Logan RF, Mora A, Hodge R, et al. Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial. BMJ Open 2015;5(4):e007230.
124. Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No: CD001888. [DOI: 10.1002/14651858.CD001888.pub4]
125. Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348(9034):1055-60.
126. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al, Clinical Transfusion Medicine Committee of the AABB. Red blood cell transfusion: a clinical practice guideline from the AABB. Annals of Internal Medicine 2012;157(1):49-58.
127. Carson JL, Sieber F, Cook DR, Hoover DR, Noveck H, Chaitman BR, et al. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet 2015;385(9974):1183-9.
128. Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, et al. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA 2016;316:2025-35.
129. Carson JL, Stanworth SJ, Alexander JH, Roubinian N, Fergusson DA, Triulzi DJ, et al. Clinical trials evaluating red blood cell transfusion thresholds: an updated systematic review and with additional focus on patients with cardiovascular disease. American Heart Journal 2018;200:96-101.
130. Chatterjee S, Wetterslev J, Sharma A, Lichstein E, Mukherjee D. Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. JAMA Internal Medicine 2013;173(2):132-9.
131. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. New England Journal of Medicine 2000;342(25):1887-92.
132. Delaney M, Wendel S, Bercovitz RS, Cid J, Cohn C, Dunbar NM, et al, Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Transfusion reactions: prevention, diagnosis, and treatment. Lancet 2016;388(10061):2825-36. [DOI: 10.1016/S0140-6736(15)01313-6]
133. Der Simonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
134. Docherty AB, O'Donnell R, Brunskill S, Trivella M, Doree C, Holst L, et al. Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis. BMJ 2016;352:i1351.
135. Docherty AB, Alam S, Shah AS, Moss A, Newby DE, Mills NL, et al, TROPICCAL Investigators. Unrecognised myocardial infarction and its relationship to outcome in critically ill patients with cardiovascular disease. Intensive Care Medicine 2018;44(12):2059-69.
136. Fominskiy E, Putzu A, Monaco F, Scandroglio AM, Karaskov A, Galas FR, et al. Liberal transfusion strategy improves survival in perioperative but not in critically ill patients. A meta-analysis of randomised trials. British Journal of Anaesthesia 2015;115(4):511-9.
137. Hébert PC, Wells G, Tweeddale M, Martin C, Marshall J, Pham B, et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. American Journal of Respiratory and Critical Care Medicine 1997;155(5):1618-23.
138. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2011, Issue 3. Art. No: CD001886. [DOI: 10.1002/14651858.CD001886.pub4]
139. Higgins JT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.
140. Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, et al. Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials. Acta Oncologica 2011;50(7):1006-14.
141. Hoff CM, Hansen HS, Overgaard M, Grau C, Johansen J, Bentzen O, et al. The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy - results from the randomized DAHANCA 5 study. Radiotherapy and Oncology 2011;1998:28-33. [DOI: 10.1016/j.radonc.2010.09.024]
142. Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ 2015;350:h1354.
143. Kunz JV, Spies CD, Bichmann A, Sieg M, Mueller A. Postoperative anaemia might be a risk factor for postoperative delirium and prolonged hospital stay: a secondary analysis of a prospective cohort study. PLOS ONE 2020;15(2):e0229325. https://doi.org/10.1371/journal.pone.0229325.
144. Kwan JL, Lo L, Ferguson J, Goldberg H, Diaz-Martinez JP, Tomlinson G, et al. Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ 2020;370:m3216:1-10. [DOI: 10.1136/bmj.m3216]
145. Lefebvre C, Manheimer E, Glanville J. Chapter 6. Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.
146. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Critical Care Medicine 2008;36(9):2667-74.
147. Mazer CD, Whitlock RP, Fergusson DA, Belley-Cote E, Connolly K, Khanykin B, et al, TRICS Investigators and Perioperative Anesthesia Clinical Trials Group. Six-month outcomes after restrictive or liberal transfusion for cardiac surgery. New England Journal of Medicine 2018;379(13):1224-33.
148. Meybohm P, Straub N, Füllenbach C, Judd L, Kleinerüschkamp A, Taeuber I, et al. Health economics of Patient Blood Management: a cost-benefit analysis based on a meta-analysis. Vox Sanguinis 2020;115(2):182-8. [DOI: 10.1186/s13063-019-3200-3]
149. Mueller MM, Van Remoortel H, Meybohm P, Aranko K, Aubron C, Burger R, et al, Group LCC Pbm Frankfurt. Patient blood management: recommendations from the 2018 Frankfurt Consensus Conference. JAMA 2019;321(10):983-97.
150. Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Critical Care Medicine 2009;37(12):3124-57.
151. National Blood Users Group Ireland (NBUGI). A guideline for transfusion of red blood cells in surgical patients. www.dohc.ie/publications/transfusion_of_red_blood_cells.html (accessed 11 October 2016).
152. New HV, Berryman J, Bolton-Maggs PH, Cantwell C, Chalmers EA, Davies T, et al, British Committee for Standards in Haematology. Guidelines on transfusion for fetuses, neonates and older children. British Journal of Haematology 2016175(5):784-828.
153. National Institutes of Health (NIH). Perioperative red blood cell transfusion. JAMA 1988;260(18):2700-3.
154. Ochocinska MJ, Spitalnik SL, Abuhamad A, Bennett-Guerrero E, Carlo WA, Cherukuri M, et al. NIH Workshop 2018: towards minimally-invasive or non-invasive approaches to assess tissue oxygenation pre- and post-transfusion. Transfusion Medicine Reviews 2020;S0887-7963(20):30074-2. [DOI: doi: 10.1016/j.tmrv.2020.12.003]
155. Odutayo A, Desborough MJ, Trivella M, Stanley AJ, Dorée C, Collins GS, et al. Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials. Lancet Gastroenterology and Hepatology 2017;2(5):354-60. [DOI: 10.1016/S2468-1253(17)30054-7]
156. Overgaard J, Hansen HS, Overgaard M, Bastholt L, Berthelsen A, Specht L, et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma: results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiotherapy and Oncology 1998;46:135-46.
157. Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Anderson E, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 & 7 randomised controlled trial. Lancet 2003;362:933-40.
158. Patel NN, Avlonitis VS, Jones HE, Reeves BC, Sterne JA, Murphy GJ. Indications for red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis. Lancet Haematology 2015;2(12):e543-53. [DOI: doi: 10.1016/S2352-3026(15)00198-2]
159. Pavenski K, Stanworth S, Fung M, Wood EM, Pink J, Murphy MF, et al, International Collaboration for Transfusion Medicine Guidelines (ICTMG). Quality of evidence-based guidelines for transfusion of red blood cells and plasma: a systematic review. Transfusion Medicine Reviews 2018;S0887-7963(18):30017-8.
160. Retter A, Wyncoll D, Pearse R, Carson D, McKechnie S, Stanworth S, et al. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. British Journal of Haematology 2013;160(4):445-64.
161. Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
162. Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5). Version 5.1. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
163. Richards T, Baikady RR, Clevenger B, Butcher A, Abeysiri S, Chau M, et al. Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial. Lancet 2020;396:1353–61.
164. Roberts I, Ker K, Edwards P, Beecher D, Manno D, Sydenham E. The knowledge system underpinning healthcare is not fit for purpose and must change. BMJ 2015;350:h2463.
165. Rohde JM, Dimcheff DE, Blumberg N, Saint S, Langa KM, Kuhn L, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 2014;311(13):1317-26.
166. Roman MA, Abbasciano RG, Pathak S, Oo S, Yusoff S, Wozniak M, et al. Patient blood management interventions do not lead to important clinical benefits or cost-effectiveness for major surgery: a network meta-analysis. British Journal of Anaesthesia 2020;S0007-0912(20):30342-1. [DOI: 10.1016/j.bja.2020.04.087]
167. Rygård SL, Holst LB, Wetterslev J, Winkel P, Johansson PI, Wernerman J, et al, TRISS Trial Group, Scandinavian Critical Care Trials Group. Long-term outcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold: the TRISS randomised, multicentre clinical trial. Intensive Care Medicine 2016;42(11):1685-94. x-wiley/crsRef/16665581
168. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005;111(16):2042-9.
169. Schulz KF, Chalmers I, Hayes RJ, Altman DJ. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled clinical trials. JAMA 1995;273(5):408-12.
170. Schünemann HJ, Oxman AD, Higgins JP, Vist GE, Flasziou P, Guyatt GH. Chapter 11. Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Review of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.
171. Shah A, Brunskill SJ, Desborough MJ, Doree C, Trivella M, Stanworth SJ. Transfusion of red blood cells stored for shorter versus longer duration for all conditions. Cochrane Database of Systematic Reviews 2018, Issue 12. Art. No: CD010801. [DOI: 10.1002/14651858.CD010801.pub3]
172. Shah A, Stanworth SJ, Docherty AB. Restrictive blood transfusion - is less really more? Anaesthesia 2020;75(4):433–7.
173. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010;50(4):753-65.
174. Shander A, Javidroozi M, Naqvi S, Aregbeyen O, Caylan M, Demir S, et al. An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME). Transfusion 2014;54(10 Pt 2):2688-95.
175. Shehata N, Mistry N, da Costa BR, Pereira TV, Whitlock R, Curley GF, et al. Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis. European Heart Journal 2019;40(13):1081-8.
176. Shih AW, Liu A, Elsharawi R, Crowther MA, Cook RJ, Heddle NM. Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies. Transfusion 2018;58(12):2841-60.
177. Narayan S (Ed), Poles D, et al, on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2019 Annual SHOT Report (2020). https://www.shotuk.org/wp-content/uploads/myimages/SHOT-REPORT-2019-Final-Bookmarked-v2.pdf.
178. Smith JD, Li DH, Rafferty MR. The implementation research logic model: a method for planning, executing, reporting, and synthesizing implementation projects. Implementation Science 2020;15(84):doi.org/10.1186/s13012-020-01041-8. [DOI: 10.1186/s13012-020-01041-8]
179. So-Osman C, Nelissen R, Te Slaa R, Coene L, Brand R, Brand A. A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells. Vox Sanguinis 2010;98(1):56-64. x-wiley/crsRef/3132592
180. Spiess BD, Ley C, Body SC, Siegel LC, Stover EP, Maddi R, et al. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Journal of Thoracic & Cardiovascular Surgery 1998;116(3):460-7.
181. Steiner ME, Ness PM, Assmann SF, Triulzi DJ, Sloan SR, Delaney M, et al. Effects of red-cell storage duration on patients undergoing cardiac surgery. New England Journal of Medicine 2015;372(15):1419-29.
182. Stokes EA, Wordsworth S, Staves J, Mundy N, Skelly J, Radford K, et al. Accurate costs of blood transfusion: a microcosting of administering blood products in the United Kingdom National Health Service. Transfusion 2018;58(4):846-53.
183. Society of Thoracic Surgeons Blood Conservation Guideline Task Force (STSBCGTF), Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Annals of Thoracic Surgery 2011;91(3):944-82.
184. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Circulation 2012;126(16):2020-35. [DOI: 10.1161/CIR.0b013e31826e1058]
185. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012;119(7):1757-67.
186. Trentino KM, Farmer SL, Leahy MF, Sanfilippo FM, Isbister JP, Mayberry R, et al. Systematic reviews and meta-analyses comparing mortality in restrictive and liberal haemoglobin thresholds for red cell transfusion: an overview of systematic reviews. BMC Medicine 2020;18:154; https://doi.org/10.1186/s12916-020-01614-w. [DOI: 10.1186/s12916-020-01614-w]
187. Trentino KM, Farmer SL, Isbister JP, Sanfilippo FM, Leahy MF, Hofmann A, et al. Restrictive versus liberal transfusion trials: are they asking the right question? Anesthesia and Analgesia 2020;131(6):1950-5. [DOI: 10.1213/ANE.0000000000005227]
188. Trivella M, Stanworth SJ, Brunskill S, Dutton P, Altman DG. Can we be certain that storage duration of transfused red blood cells does not affect patient outcomes? BMJ 2019;365:l2320.
189. Turner ML. Safety of blood, blood derivatives, and plasma-derived products,. Handbook of Clinical Neurology 2018;153:463-72.
190. Vlaar AP, Oczkowski S, de Bruin S, Wijnberge M, Antonelli M, Aubron C, et al. Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. Intensive Care Medicine 2020;46:673-96. x-wiley/crsRef/16665655
191. Wang JK, Klein HG. Red blood cell transfusion in the treatment and management of anaemia: the search for the elusive transfusion trigger. Vox Sanguinis 2010;98(1):2-11.
192. US Department of Health and Human Services, Office of the Assistant Secretary for Health. Report of the US Department of Health and Human Services. The 2009 National Blood Collection and Utilization Survey Report. www.hhs.gov/ophs/bloodsafety/2007nbcus_survey.pdf (accessed 11 October 2016).
193. WHO. Global status report on blood safety and availability. www.who.int/worldblooddonorday/media/who_blood_safety_factsheet_2011.pdf (accessed 17 January 2021);Fact Sheet 279:1-173.
194. Whyte R, Kirpalani H. Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infants. Cochrane Database of Systematic Reviews 2011, Issue 11. Art. No: CD000512. [DOI: 10.1002/14651858.CD000512.pub2]
195. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. New England Journal of Medicine 2001;345(17):1230-6.
196. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007;297(22):2481-8.
197. Wu WC, Smith TS, Henderson WG, Eaton CB, Poses RM, Uttley G, et al. Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Annals of Surgery 2010;252(1):11-7.
198. Yao RQ, Ren C, Zhang ZC, Zhu YB, Xia ZF, Yao YM. Is haemoglobin below 7.0 g/dL an optimal trigger for allogenic red blood cell transfusion in patients admitted to intensive care units? A meta-analysis and systematic review. BMJ Open 2020;10:e030854. x-wiley/crsRef/16665661
199. Youssef LA, Spitalnik SL. Transfusion-related immunomodulation: a reappraisal. Current Opinion in Hematology 2017;24(6):551-7.
200. Zou S, Stramer SL, Notari EP, Kuhns MC, Krysztof D, Musavi F, et al. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion 2009;49(8):1609-20.
201. Zou S, Dorsey KA, Notari EP, Foster GA, Krysztof DE, Musavi F, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010;50(7):1495-504.
202. Carless PA, Henry DA, Carson JL, Hebert PC, McClelland B, Ker K. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2010, Issue 10. Art. No: CD002042. [DOI: 10.1002/14651858.CD002042.pub2]
203. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No: CD002042. [DOI: 10.1002/14651858.CD002042.pub3]
204. Carson JL, Stanworth SJ, Roubinian N, Fergusson DA, Triulzi D, Doree C, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2016, Issue 10. Art. No: CD002042. [DOI: 10.1002/14651858.CD002042]
205. Hill S, Carless PA, Henry DA, Carson JL, Hebert PPC, Henderson KM, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2000, Issue 1. Art. No: CD002042. [DOI: 10.1002/14651858.CD002042]
206. Hill SR, Carless PA, Henry DA, Carson JL, Hebert PC, McClelland DB, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No: CD002042. [DOI: 10.1002/14651858.CD002042]
207. Hill SR, Carless PA, Henry DA, Carson JL, Hebert PC, McClelland DB, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No: CD002042. [DOI: 10.1002/14651858.CD002042]